Heidelberg Pharma Ag Stock Cash Per Share
| HPHA Stock | EUR 2.32 0.07 2.93% |
Heidelberg Pharma AG fundamentals help investors to digest information that contributes to Heidelberg Pharma's financial success or failures. It also enables traders to predict the movement of Heidelberg Stock. The fundamental analysis module provides a way to measure Heidelberg Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Heidelberg Pharma stock.
Heidelberg |
Heidelberg Pharma AG Company Cash Per Share Analysis
Heidelberg Pharma's Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
| Competition |
In accordance with the recently published financial statements, Heidelberg Pharma AG has a Cash Per Share of 0.0 times. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Cash Per Share (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
Heidelberg Cash Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Heidelberg Pharma's direct or indirect competition against its Cash Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Heidelberg Pharma could also be used in its relative valuation, which is a method of valuing Heidelberg Pharma by comparing valuation metrics of similar companies.Heidelberg Pharma is currently under evaluation in cash per share category among its peers.
Heidelberg Fundamentals
| Current Valuation | 194.72 M | |||
| Price To Book | 24.79 X | |||
| Price To Sales | 12.52 X | |||
| Revenue | 1.75 M | |||
| EBITDA | (24.84 M) | |||
| Net Income | (26.14 M) | |||
| Cash Flow From Operations | (26.61 M) | |||
| Market Capitalization | 173.26 M | |||
| Total Asset | 21.73 M | |||
| Z Score | -3.3 | |||
| Net Asset | 21.73 M |
About Heidelberg Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Heidelberg Pharma AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Heidelberg Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Heidelberg Pharma AG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Other Information on Investing in Heidelberg Stock
Heidelberg Pharma financial ratios help investors to determine whether Heidelberg Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Heidelberg with respect to the benefits of owning Heidelberg Pharma security.